Literature DB >> 9420873

Abnormal gene expression in uterine leiomyomas.

J Andersen1, R L Barbieri.   

Abstract

Uterine leiomyomas, benign tumors of myometrial origin, are the most common neoplasms of the uterus and occur in 20-30% of women over 30 years of age. Despite their high prevalence, little is known about the pathophysiology of these tumors. Recently, several studies have compared leiomyoma gene expression with that of normal myometrium. In general, the major differences in leiomyoma and myometrial gene expression are found for estrogen-regulated genes, which have elevated expression in myometrium during pregnancy. The tumors appear to maintain high sensitivity to estrogen during the estrogen-dominated follicular phase of the menstrual cycle, unlike normal myometrium. The abnormal gene expression of leiomyomas suggests that they are tumors of dysregulated differentiation and resemble the myometrium of pregnancy in several aspects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9420873     DOI: 10.1016/1071-5576(95)00021-6

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  22 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

2.  Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.

Authors:  Sergio A Machado; Janice M Bahr; D Buck Hales; Andrea G Braundmeier; Bradley J Quade; Romana A Nowak
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

Review 3.  Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.

Authors:  Molly B Moravek; Serdar E Bulun
Journal:  Curr Opin Obstet Gynecol       Date:  2015-08       Impact factor: 1.927

Review 4.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

5.  History of uterine leiomyomata and incidence of breast cancer.

Authors:  Lauren A Wise; Rose G Radin; Lynn Rosenberg; Lucile Adams-Campbell; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2015-08-07       Impact factor: 2.506

Review 6.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

7.  5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors.

Authors:  Antonia Navarro; Ping Yin; Masanori Ono; Diana Monsivais; Molly B Moravek; John S Coon; Matthew T Dyson; Jian-Jun Wei; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2014-07-24       Impact factor: 5.958

8.  Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment.

Authors:  Digna R Velez Edwards; Donna D Baird; Katherine E Hartmann
Journal:  Am J Epidemiol       Date:  2013-06-30       Impact factor: 4.897

9.  Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.

Authors:  William H Catherino; Heba M Eltoukhi; Ayman Al-Hendy
Journal:  Semin Reprod Med       Date:  2013-08-09       Impact factor: 1.303

10.  Oral contraceptives after myomectomy: a short term trial.

Authors:  Stefano Luisi; Valentina Ciani; Massimo Gabbanini; Sofia Sollazzi; Michela Torricelli; Francesco Calonaci; Felice Petraglia
Journal:  Int J Endocrinol       Date:  2009-07-28       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.